Sep 2026· Multiple Sclerosis and Related Disorders· Vol 115, pp.
107910
· 0 citations· 82 references
Medicine
Abstract
Background
This study aimed to provide an updated estimate of the prevalence and incidence of multiple sclerosis (MS) in Iran.
Method
To ensure the methodological rigor of this review, the protocol was developed in accordance with the MOOSE guidelines, and results were reported based on PRISMA statement. Two independent reviewers systematically searched national and international databases using MeSH terms from inception to January 1, 2026, without time restrictions. Data were pooled using Comprehensive Meta-Analysis software version 2, applying a random-effects model. A p-value of <0.05 was considered statistically significant.
Results
A total of 56 articles comprising 142 individual studies were included in meta-analysis. The overall prevalence of MS in Iran, based on 139 studies, was estimated at 33.7 per 100,000 population (33.7/ 100,000) (95%CI: 30.9-39.0). The prevalence was 23.8/ 100,000 (95%CI: 21.0-27.0) in men and 76.0/ 100,000 (95%CI: 67.5-85.5) in women. Based on 80 studies, the incidence of MS in Iran was estimated at 4.2/ 100,000 (95%CI: 2.7-6.6), with an incidence of 2.2/ 100,000 (95%CI: 1.9-2.4) in men and 6.7/100,000 (95%CI: 5.9-7.5) in women. Meta-regression analysis revealed a statistically significant upward trend in both prevalence and incidence of MS in Iran over time (P < 0.001).
Conclusions
The findings demonstrate that both the prevalence and incidence of MS in Iran are considerable and have significantly increased over time, emphasizing the need for further investigation into context-specific risk factors within the country.
Depression can negatively impact the quality of life, treatment compliance, and prognosis in tuberculosis (TB) patients. India accounts for one-third of the TB population worldwide. Our study aimed to find the prevalence of depression in TB patients in India. PubMed, Web of Science, PsycINFO, and SCOPUS were search...
K. Narasimhappa, Priyanka N. Kodahonna, P. Sahadevan et al.· Indian Journal of Community...· 0 citations
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with diverse clinical manifestations that significantly affect patients’ quality of life. Arthritis is one of the most common and disabling manifestations of SLE. This study aimed to provide a comprehensive estimate of the prevalence of arthritis among...
M. Khan, Humera Qureshi, Fazal Hassan et al.· Journal of Epidemiology and...· 0 citations
OBJECTIVE
The objective of this scoping review was to synthesize evidence on the proportion of individuals living with Sjögren's disease who experience central nervous system (CNS) manifestations.
METHODS
We searched MEDLINE (via PubMed) and Embase from 1980 through January 29, 2026, and the ECRI Guidelines Trust fro...
A. Varadhachary, G. Noaiseh, J. Frantsve-Hawley et al.· Arthritis care & research· 0 citations
Childhood-onset systemic lupus erythematosus (cSLE) is frequently associated with psychological symptoms, particularly depression. However, there remains a lack of quantitative evidence regarding the prevalence of screening-positive depressive symptoms based on the currently available evidence. In this context, we...
Xiao-Jing Xia, Min Pan· Frontiers in Pediatrics· 0 citations
INTRODUCTION
Given the ongoing debate surrounding the validity of Autoimmune/ Inflammatory Syndrome Induced by Adjuvants (ASIA), this study aimed to evaluate the clinical evidence related to this syndrome, with particular emphasis on its major diagnostic criteria and methodological quality.
METHODS
A systematic revie...
G. Ramírez-Luna, Álvaro Arbeláez Cortés, David Julián Del-Castillo-Gil· Current Rheumatology Reviews· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.